0.047
price down icon6.00%   -0.003
after-market Dopo l'orario di chiusura: .04 -0.007 -14.89%
loading

Psyence Biomedical Ltd Borsa (PBM) Ultime notizie

pulisher
03:20 AM

Psyence Biomed granted Nasdaq listing extension By Investing.com - Investing.com Australia

03:20 AM
pulisher
Nov 20, 2024

Psyence Biomedical Secures Extension To Meet Nasdaq Compliance Standards - Benzinga

Nov 20, 2024
pulisher
Nov 20, 2024

Psyence Biomedical to consolidate shares in bid to keep Nasdaq listing - Green Market Report

Nov 20, 2024
pulisher
Nov 20, 2024

Psyence Biomedical gets extension to show compliance with Nasdaq’s listing rules - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Psyence Biomedical Announces Favorable Result of Nasdaq Listing Qualifications Hearing - The Manila Times

Nov 20, 2024
pulisher
Nov 20, 2024

Psyence Biomed granted Nasdaq listing extension - Investing.com

Nov 20, 2024
pulisher
Nov 20, 2024

Psyence Biomedical Announces Favorable Result Of Nasdaq Listing Qualifications Hearing - XM

Nov 20, 2024
pulisher
Nov 20, 2024

Psyence Biomedical Secures Nasdaq Extension, Plans 1-for-75 Share Consolidation | PBM Stock News - StockTitan

Nov 20, 2024
pulisher
Nov 20, 2024

Psyence Biomedical fell on 75-to-1 share consolidation and Nasdaq delisting notice - MSN

Nov 20, 2024
pulisher
Nov 19, 2024

Psyence Biomed announces share consolidation date - Investing.com India

Nov 19, 2024
pulisher
Nov 19, 2024

Psyence Biomedical Announces Effective Date for 1-for-75 Share Consolidation - The Manila Times

Nov 19, 2024
pulisher
Nov 19, 2024

Psyence Biomedical Implements 1-for-75 Share Consolidation to Meet Nasdaq Requirements | PBM Stock News - StockTitan

Nov 19, 2024
pulisher
Nov 19, 2024

Psyence Biomed announces share consolidation date By Investing.com - Investing.com Canada

Nov 19, 2024
pulisher
Nov 13, 2024

Psyence Biomedical Announces Results from Annual and Special General Meeting, Share Consolidation and Receipt of Additional Staff Determination from Nasdaq - The Manila Times

Nov 13, 2024
pulisher
Nov 12, 2024

Psyence Biomedical Shareholders Approve 75:1 Stock Split Amid Nasdaq Compliance Challenge | PBM Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 12, 2024

Psyence Biomedical Announces Results from Annual and - GlobeNewswire

Nov 12, 2024
pulisher
Oct 31, 2024

Psyence Biomedical Announces Closing of Previously Announced Acquisition of Psyence Group’s Stake in PsyLabs - GlobeNewswire

Oct 31, 2024
pulisher
Oct 31, 2024

Psyence Group Announces Closing of Previously Announced Disposal of its Stake in PsyLabs - Yahoo Finance

Oct 31, 2024
pulisher
Oct 31, 2024

Psyence Biomedical Announces Closing of Previously Announced Acquisition of Psyence Group's Stake in PsyLabs - The Manila Times

Oct 31, 2024
pulisher
Oct 30, 2024

Where Do Analysts See Psyence Biomedical Ltd. (NASDAQ: PBM) Heading? - Stocks Register

Oct 30, 2024
pulisher
Oct 26, 2024

Bullish Prospects For Psyence Biomedical Ltd. (NASDAQ: PBM) Shares In 2024 - Stocks Register

Oct 26, 2024
pulisher
Oct 25, 2024

Natural Gas LDay (F) (HHM19) Quote - The Globe and Mail

Oct 25, 2024
pulisher
Oct 25, 2024

Psyence Biomed adds Australian site for psilocybin trial - Investing.com

Oct 25, 2024
pulisher
Oct 24, 2024

Psyence Biomed adds Australian site for psilocybin trial By Investing.com - Investing.com South Africa

Oct 24, 2024
pulisher
Oct 24, 2024

Psyence Biomed Announces Recruitment of Second Clinical - GlobeNewswire

Oct 24, 2024
pulisher
Oct 24, 2024

Psyence Biomed Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care - StockTitan

Oct 24, 2024
pulisher
Oct 23, 2024

Psyence Biomedical Sets Annual General Meeting for November 12 - Investing.com

Oct 23, 2024
pulisher
Oct 23, 2024

Psyence Biomedical Plans Key Shareholder Meeting - TipRanks

Oct 23, 2024
pulisher
Oct 23, 2024

Psyence Biomedical Sets Annual General Meeting for November 12 By Investing.com - Investing.com UK

Oct 23, 2024
pulisher
Oct 17, 2024

Psyence Biomed Provides Progress Update on PsyLabs E.U. Good Manufacturing Practices (GMP) Certified Active Pharmaceutical Ingredient (API) Development - The Manila Times

Oct 17, 2024
pulisher
Oct 14, 2024

Psyence Biomedical Ltd. (PBM) Stock: 52-Week Performance Insights and Trading Volume - The InvestChronicle

Oct 14, 2024
pulisher
Oct 14, 2024

How analysts predict Psyence Biomedical Ltd. (PBM) will perform this quarter? - US Post News

Oct 14, 2024
pulisher
Oct 14, 2024

Psyence Group Enters into Debt-for-Equity Swap Agreement with its NASDAQ-Listed Associate, Psyence Biomedical - The Manila Times

Oct 14, 2024
pulisher
Oct 14, 2024

Gaining Ground: Psyence Biomedical Ltd. (PBM) Closes Higher at 0.10, Up 5.70 - The Dwinnex

Oct 14, 2024
pulisher
Oct 14, 2024

What is Psyence Biomedical Ltd. (PBM) Stock Return on Shareholders’ Capital? - SETE News

Oct 14, 2024
pulisher
Oct 09, 2024

Psyence Biomedical Ltd. [PBM] is -98.82% lower this YTD. Is it still time to buy? - The DBT News

Oct 09, 2024
pulisher
Oct 09, 2024

Investor Alert: What’s Really Going On At Psyence Biomedical Ltd. (NASDAQ: PBM) - Stocks Register

Oct 09, 2024
pulisher
Oct 09, 2024

There is no way Psyence Biomedical Ltd. (PBM) can keep these numbers up - SETE News

Oct 09, 2024
pulisher
Oct 08, 2024

Psyence Biomedical Converts Debt to Equity - TipRanks

Oct 08, 2024
pulisher
Oct 08, 2024

PBM’s Stock Journey: What Investors Need to Know About Psyence Biomedical Ltd.’s Performance - The InvestChronicle

Oct 08, 2024
pulisher
Oct 07, 2024

Is it possible to buy Psyence Biomedical Ltd.(PBM) shares at a good price now? - US Post News

Oct 07, 2024
pulisher
Oct 07, 2024

Financial Analysis: Psyence Biomedical Ltd. (PBM)’s Ratios Unveil Key Insights - The Dwinnex

Oct 07, 2024
pulisher
Oct 05, 2024

PBMPsyence Biomedical Ltd. Common Shares Latest Stock News & Market Updates - StockTitan

Oct 05, 2024
pulisher
Oct 05, 2024

Psyence Biomed halts Clairvoyant Therapeutics acquisition - Investing.com

Oct 05, 2024
pulisher
Oct 04, 2024

Psyence Biomed halts Clairvoyant Therapeutics acquisition By Investing.com - Investing.com UK

Oct 04, 2024
pulisher
Oct 04, 2024

Psyence Biomed Provides Update on Previously Announced Acquisition of Clairvoyant - The Manila Times

Oct 04, 2024
pulisher
Oct 02, 2024

Views of Wall Street’s Leading Experts on Psyence Biomedical Ltd. - SETE News

Oct 02, 2024
pulisher
Sep 30, 2024

Psyence Biomedical Ltd. (PBM) Stock: Uncovering 52-Week Market Trends - The InvestChronicle

Sep 30, 2024
pulisher
Sep 30, 2024

Market Momentum: Psyence Biomedical Ltd. (PBM) Registers a -1.10 Decrease, Closing at 0.11 - The Dwinnex

Sep 30, 2024
pulisher
Sep 30, 2024

Psyence Biomedical Ltd. (PBM) stock analysis: A comprehensive overview - US Post News

Sep 30, 2024
pulisher
Sep 27, 2024

Psyence Biomedical Ltd. (PBM): Be Patient, You Will Learn - Stocks Register

Sep 27, 2024
pulisher
Sep 25, 2024

An analyst sees good growth prospects for Psyence Biomedical Ltd. (PBM) - SETE News

Sep 25, 2024
pulisher
Sep 24, 2024

Psyence Group offloads PsyLabs stake to spinoff - Green Market Report

Sep 24, 2024
pulisher
Sep 23, 2024

A stock that deserves closer examination: Psyence Biomedical Ltd. (PBM) - US Post News

Sep 23, 2024
pulisher
Sep 23, 2024

Stock Performance Spotlight: Psyence Biomedical Ltd. (PBM) Ends the Day at 0.12, Down by -6.11 - The Dwinnex

Sep 23, 2024
pulisher
Sep 20, 2024

Psyence Group Sells Stake to Psyence Biomedical - TipRanks

Sep 20, 2024
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
Capitalizzazione:     |  Volume (24 ore):